CI Investments Inc. Has $509.39 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

CI Investments Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 4.1% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 991,752 shares of the healthcare conglomerate’s stock after buying an additional 39,104 shares during the period. UnitedHealth Group accounts for approximately 2.4% of CI Investments Inc.’s investment portfolio, making the stock its 5th largest holding. CI Investments Inc. owned approximately 0.11% of UnitedHealth Group worth $509,394,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in UNH. Urban Wealth Management LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $29,000. Knott David M Jr bought a new position in shares of UnitedHealth Group in the 2nd quarter worth $29,000. Rothschild & Co Wealth Management UK Ltd bought a new stake in UnitedHealth Group in the second quarter valued at about $31,000. Enterprise Trust & Investment Co bought a new position in UnitedHealth Group during the second quarter worth about $39,000. Finally, Apeiron RIA LLC raised its position in shares of UnitedHealth Group by 3.3% in the 2nd quarter. Apeiron RIA LLC now owns 2,518 shares of the healthcare conglomerate’s stock valued at $40,000 after acquiring an additional 80 shares during the period. Institutional investors and hedge funds own 87.25% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.40% of the stock is owned by insiders.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. Credit Suisse Group lifted their price target on shares of UnitedHealth Group from $579.00 to $590.00 and gave the stock an “outperform” rating in a research report on Monday, October 17th. Morgan Stanley reaffirmed an “overweight” rating and set a $587.00 price target on shares of UnitedHealth Group in a research report on Wednesday. initiated coverage on shares of UnitedHealth Group in a report on Wednesday, October 12th. They set a “strong-buy” rating on the stock. Raymond James downgraded UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price objective for the company. in a report on Monday. Finally, SVB Leerink decreased their price objective on UnitedHealth Group from $625.00 to $618.00 and set an “outperform” rating for the company in a report on Monday, October 17th. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $595.11.

UnitedHealth Group Price Performance

Shares of UNH traded up $6.62 during trading hours on Thursday, hitting $529.71. 2,238,349 shares of the company were exchanged, compared to its average volume of 3,418,937. UnitedHealth Group Incorporated has a fifty-two week low of $438.21 and a fifty-two week high of $558.10. The firm’s fifty day moving average is $524.05 and its 200 day moving average is $515.70. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.58. The company has a market cap of $494.93 billion, a price-to-earnings ratio of 25.94, a P/E/G ratio of 1.63 and a beta of 0.75.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, October 14th. The healthcare conglomerate reported $5.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.45 by $0.34. The business had revenue of $80.89 billion for the quarter, compared to analyst estimates of $80.54 billion. UnitedHealth Group had a net margin of 6.17% and a return on equity of 26.59%. The firm’s revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter last year, the business posted $4.52 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 22.01 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 13th. Stockholders of record on Monday, December 5th will be issued a $1.65 dividend. The ex-dividend date of this dividend is Friday, December 2nd. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.25%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 32.32%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with's FREE daily email newsletter.